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Background: Acetoin is a promising chemical compound that can potentially serve as a high value-added platform
for a broad range of applications. Many industrial biotechnological processes are moving towards the use of yeast
as a platform. The multi-auxotrophic yeast, Candida glabrata, can accumulate a large amount of pyruvate, but produces
only trace amounts of acetoin. Here, we attempted to engineer C. glabrata to redirect the carbon flux of pyruvate
to increase acetoin production.
Results: Based on an in silico strategy, a synthetic, composite metabolic pathway involving two distinct enzymes,
acetolactate synthase (ALS) and acetolactate decarboxylase (ALDC), was constructed, leading to the accumulation
of acetoin in C. glabrata. Further genetic modifications were introduced to increase the carbon flux of the
heterologous pathway, increasing the production of acetoin to 2.08 g/L. Additionally, nicotinic acid was employed
to regulate the intracellular NADH level, and a higher production of acetoin (3.67 g/L) was obtained at the
expense of 2,3-butanediol production under conditions of a lower NADH/NAD+ ratio.
Conclusion: With the aid of in silico metabolic engineering and cofactor engineering, C. glabrata was designed
and constructed to improve acetoin production.
Keywords: Acetoin, Candida glabrata, Cofactor engineering, Heterologous pathway, In silico, Metabolic
engineeringBackground
Acetoin (3-hydroxy-2-butanone) is known to be a major
volatile compound, naturally present in wine, cocoa, but-
ter, honey, coffee, strawberries, etc. Additionally, as a
member of the C4-dicarboxylic acid family, acetoin was
also defined as one of the potential top 30 sugar-derived
chemical building blocks by the U.S. Department of
Energy [1], and has drawn much interest because it could
serve as a high value-added platform for the food, flavor,
cosmetics, pharmaceutical, and chemical industries [2,3].
At present, three methods are used to produce acetoin: mi-
crobial fermentation, enzymatic conversion, and chemical
synthesis [4]. Of those, microbial fermentation is the more
cost-effective approach owing to the low cost of raw mate-
rials, mild process conditions, and high purity of product
[5,6]. However, acetoin is only a minor by-product in mixed
acid fermentation in a number of microorganisms, such as* Correspondence: mingll@jiangnan.edu.cn; jchen@jiangnan.edu.cn
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unless otherwise stated.Lactococcus lactis [5], Bacillus subtilis [6], Klebsiella pneu-
monia [7], and Bacillus amyloliquefaciens [8]. In addition,
because of the issues of safety, microbial robustness, and
phage contamination, industrial-scale production of acetoin
has not yet been realized using these strains. Therefore, the
biological platform for microbial acetoin production needs
to be further refined and improved.
Recently, many industrial biotechnological processes
are moving towards the use of yeast as a platform be-
cause it can withstand lower temperatures and is associ-
ated with easier separation of products, lack of phage
contamination, ease of scale-up, lower pH tolerance, and
greater robustness [9]. However, only small quantities of
acetoin (< 500 mg/L) can be accumulated in wild-type
yeast [10]. Furthermore, some factors, including the lack
of extensive genetic and metabolic information, the selec-
tion of targeted genes, and the unpredictability of cellular
physiological responses, have inhibited and raised some
challenges for attempts to metabolically engineer improvedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Li et al. Microbial Cell Factories 2014, 13:55 Page 2 of 11
http://www.microbialcellfactories.com/content/13/1/55cellular phenotypes of yeast in the post-genomic era
[11,12]. To this end, the genome-scale metabolic models
(GSMMs) of microorganisms, such as E. coli [13], S.
cerevisiae [14], and Candida glabrata [15], have been
reconstructed and used to identify genes that could be tar-
geted for improving strains on a global level. With the aid
of in silico simulation, systems metabolic engineering has
opened a novel avenue for engineering microorganisms to
produce value-added products [16,17].
As a multi-auxotrophic yeast, C. glabrata can accumulate
a large amount of pyruvate, providing an abundance of pre-
cursor for acetoin production [18]. With the availability of a
fully sequenced genome and the reconstructed metabolic
model i NX804, engineering C. glabrata can now be
achieved more effectively and directly. However, owing to
the inhibition of pyruvate decarboxylation and the intense
spontaneous reaction of non-enzymatic oxidative decarb-
oxylation (NOD), only 45 mg/L acetoin was accumulated
in wild-type C. glabrata . Therefore, constructing a heterol-
ogous pathway in the cytosol may be the better option for
acetoin production. As shown in Figure 1, the heterologous
pathway converts pyruvate, the end metabolite of the
glycolysis pathway, into acetoin via two enzymatic steps,
which are catalyzed by α-acetolactate synthetase (ALS)
[E.C.2.2.1.6] and α-acetolactate decarboxylase (ALDC)
[E.C.4.1.1.5]. In this work, with the aid of in silico
simulation, the heterologous pathway was designed and
constructed for acetoin production in C. glabrata and,
meanwhile, a series of genetic modifications were also
applied to further increase acetoin production, demon-
strating that C. glabrata is a promising candidate for
production of acetoin on an industrial scale.Figure 1 Metabolic pathways of acetoin in C. glabrata: the original an
pathways were: acetolactate synthase (ILV2 + ILV6, ALS), acetolactate decarbo
(BDH), acetohydroxy acid isomeroreductase (ILV5). The abbreviations are: BCA
non-enzymatic oxidative decarboxylation.Results
Identification of the optimum pathway for acetoin production
By extensive mining of the literature and from the se-
quenced genome, two pathways for acetoin production,
including pyruvate decarboxylation and non-enzymatic
oxidative decarboxylation, were originally annotated in
C. glabrata [10]. Considering the characteristics of C.
glabrata, the production of acetoin was zero setting cell
growth as the objective equation. To realize acetoin ac-
cumulation in C. glabrata, its metabolic capacity was
then engineered by introducing a heterologous pathway
in the cytosol, and evaluated by in silico simulation. Ac-
cording to the approach previously described [19-21],
the reactions representing the enzymatic activities of α-
acetolactate synthetase (ALS) and α-acetolactate decarb-
oxylase (ALDC) were added into the model i NX804
prior to flux balance analysis, using acetoin as the ob-
jective equation by the FBA algorithm (Additional file
1a). As a result, the theoretical production rate of acet-
oin increased by 0.24 mmol/g DCW/h from 2.03 mmol/
g DCW/h of acetoin, was accumulated when optimizing
the biomass formation (Figure 2). Therefore, the in silico
simulation showed that acetoin production could be en-
hanced by the additional reactions of ALS and ALDC,
demonstrating that the heterologous pathway could be
the better choice for acetoin production. Correspond-
ingly, two genetic manipulation steps were carried out to
implement the desired flux network in C. glabrata.
Construction and optimization of the heterologous pathway
To construct the heterologous pathway, four different
sources of ALS and ALDC were individually expressed ind heterologous metabolic pathways. The enzymes that catalyze the
xylase (ALDC), pyruvate decarboxylase (PDC); butanediol dehydrogenase



































Figure 2 Calculation of the heterologous pathway for acetoin production by in silico simulation. The production of acetoin was simulated
based on 10 mmol/gDCW/h of glucose uptake from two angles: setting cell growth as the objective function or maximizing acetoin production
under 90% of the maximum μ.
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four ALS constructs, the highest values of ALS activity
(0.81 U/mg protein from B. subtilis) and α-acetolactate
concentration (0.70 g/L) were observed in strain MuA3,
which were, respectively, 5.4-fold and 6.5-fold higher than
the values observed for MuA0. However, the production of
acetoin increased only slightly to 0.077 g/L, which was far
below the production of α-acetolactate (Table 1). Addition-
ally, diacetyl production also increased to 0.45 g/L from
0.02 g/L in strain MuA3. Thus, a suitable ALDC needed to
be introduced for acetoin production. As shown in Table 1,
because of the over-expression of ALDC, the highest ALDC
specific activity was increased to 1.85 U/mg protein (from
B. amyloliquefaciens) in strain MuA5. As a result, the pro-
duction of acetoin increased to 0.14 g/L but no diacetyl wasTable 1 Effects of gene over-expression on the enzymes and
Strains Gene Species ALS α
(U/mg protein) (g
MuA0 nt nt 0.15 ± 0.01 0
MuA1 alsS B. amyloliquefaciens 0.75 ± 0.05 0
MuA2 alsS B. pumilus 0.60 ± 0.05 0
MuA3 alsS B. subtilis 0.81 ± 0.05 0
MuA4 alsS E. coli 0.77 ± 0.1 0
MuA5 alsD B. amyloliquefaciens 0.15 ± 0.01 0
MuA6 alsD B. pumilus 0.14 ± 0.012 0
MuA7 alsD B. subtilis 0.15 ± 0.02 0
MuA8 alsD E. coli 0.13 ± 0.01 0
aThe engineered strains were grown in fermentation medium, and the production o
during batch flask culture. Results are the average of three replicates with error barobserved, indicating that α-acetolactate was completely
decarboxylated, and became the rate-limiting step for acet-
oin production in ALDC constructs.
Accordingly, the best performing ALS and ALDC were
co-expressed to construct the heterologous pathway in
strain MuA9, in which the production of acetoin was in-
creased to 1.14 g/L (Table 2). However, the accumulation of
pyruvate was greater than the level of acetoin by 21-fold,
giving 24 g/L. To address the bottleneck, a push-and-pull
strategy that combines the amplification of an upstream
pathway, with a similar increase in the flux of a down-
stream pathway, was adopted for strain improvement via
the optimization of promoters. As shown in Figure 3, three
promoters (PTPI, PGPD, PTEF ) were selected for study, and
it was found that suitable promoters had a positive effectmetabolitesa
-acetolactate Diacetyl ALDC Acetoin
/L) (g/L) (U/mg protein) (g/L)
.11 ± 0.01 0.02 ± 0.00 ND 0.041 ± 0.002
.58 ± 0.02 0.37 ± 0.02 ND 0.054 ± 0.003
.47 ± 0.03 0.33 ± 0.03 ND 0.053 ± 0.001
.70 ± 0.05 0.45 ± 0.02 ND 0.077 ± 0.004
.62 ± 0.04 0.42 ± 0.04 ND 0.065 ± 0.002
.11 ± 0.01 ND 1.85 ± 0.05 0.14 ± 0.04
.11 ± 0.01 ND 1.66 ± 0.05 0.12 ± 0.03
.12 ± 0.02 ND 1.71 ± 0.05 0.13 ± 0.06
.10 ± 0.02 ND 1.57 ± 0.1 0.12 ± 0.02
f metabolites in the culture supernatant was determined by HPLC at 64 h
s indicating standard error from the mean. ND, Not detected; nt, Not.




MuA0 (A) MuA9 (B)
DCW (g/L) 10.84 ± 0.6 10.34 ± 0.5 −0.05
Pyruvate (g/L) 30.7 ± 1.2 24.4 ± 0.8 −0.20
Specific activity of ALS (U/mg protein) 0.16 ± 0.01 0.83 ± 0.04 4.19
Specific activity of ALDC (U/mg protein) ND 1.86 ± 0.03 –
Acetolactate (g/L) 0.12 ± 0.01 0.74 ± 0.01 5
Acetoin (g/L) 0.042 ± 0.008 1.14 ± 0.05 26
Acetoin yield (g/g DCW) 0.003 0.11 35
2,3-Butanediol (g/L) 0.035 ± 0.004 0.88 ± 0.04 24
Diacetyl (g/L) 0.01 ± 0.00 ND –
Ethanol (g/L) 0.87 ± 0.02 2.15 ± 0.2 1.47
Glycerol (g/L) 0.66 ± 0.04 1.15 ± 0.1 0.74
aResults are the average of three replicates with error bars indicating standard error from the mean. ND, Not detected.
Li et al. Microbial Cell Factories 2014, 13:55 Page 4 of 11
http://www.microbialcellfactories.com/content/13/1/55on the production of acetoin. Compared to the control
(MuA9), the highest specific activities of ALS and ALDC
were obtained in strain MuA13 (harboring plasmid
pY26-TEF- ALS- GPD- ALDC), in which they in-
creased to 1.05 and 2.06 U/mg protein, respectively,
due to the optimization of promoter combinations
(Table 3). And correspondingly, the titer of acetoin also
significantly increased, reaching 1.96 g/L, which was,
respectively, 73.5%, 29.8%, 13.3%, and 17.4% higher than
that of strains MuA9, MuA10, MuA11, and MuA12.
Additionally, the highest yields of 2,3-butanediol and
ethanol were obtained in strain MuA13, reaching 1.32
g/L and 3.72 g/L, which were, respectively, 50.0% and
73.0% higher than those of strain MuA9. Through en-
hancing the activities of ALS and ALDC, more carbon




















Figure 3 Improvements in the production of acetoin, 2,3-butanediol
of three replicates with error bars indicating standard error from the mean
MuA13 (PTEF+GPD)).Comparison of intracellular and extracellular acetoin
To evaluate the suitability of C. glabrata as a host for acet-
oin production, the ability to transport acetoin into the
culture supernatant was investigated through determining
the ratio of intracellular to extracellular acetoin produc-
tion. In a defined number of cells, the amount of intra-
cellular acetoin was compared to the accumulation of
extracellular acetoin, which was produced and exported
by those cells in shake-flask fermentation with strain
MuA13. As a result, the intracellular and extracellular
acetoin production reached 32 mg/L and 2.04 g/L,
respectively, and a ratio of 1:65 ± 6 (intracellular: extra-
cellular, data represent the average of biological dupli-
cates) was obtained, indicating that C. glabrata could
efficiently transport acetoin into the culture super-
natant, and perform as an attractive host for acetoin
production.MuA11 MuA12 MuA13
tanediol Ethanol
and ethanol by using different promoters. Results are the average
(MuA9 (PTPI+TPI), MuA10 (PGPD+GPD), MuA11 (PTEF+TEF), MuA12 (PGPD+TEF),
Table 3 Effects of different genetic modifications on acetoin fermentation
Parameters* Strains
MuA13 MuA14 MuA15
DCW (g/L) 10.27 ± 0.5 9.96 ± 0.4 10.13 ± 0.5
Pyruvate (g/L) 18.4 ± 0.7 16.8 ± 0.8 16.3 ± 1.1
α-acetolactate 0.72 ± 0.02 0.81 ± 0.01 0.74 ± 0.02
Specific activity of ALS (U/mg protein) 1.05 ± 0.03 1.07 ± 0.05 1.04 ± 0.04
Specific activity of ALDC (U/mg protein) 2.06 ± 0.06 2.03 ± 0.05 2.10 ± 0.1
Acetoin (g/L) 1.96 ± 0.3 2.13 ± 0.3 2.08 ± 0.2
Acetoin yield (g/g DCW) 0.19 0.21 0.21
2,3-Butanediol (g/L) 1.36 ± 0.03 1.45 ± 0.07 2.03 ± 0.03
Acetoin/2,3-Butanediol 1.44 1.47 1.02
Ethanol (g/L) 3.67 ± 0.11 2.96 ± 0.13 2.72 ± 0.2
Acetate (g/L) 0.64 ± 0.05 0.51 ± 0.05 0.83 ± 0.1
Glycerol (g/L) 1.01 ± 0.1 1.07 ± 0.12 1.12 ± 0.12
Intracellular NAD+ (mg/g DCW) 16.1 ± 1.2 14.6 ± 1.7 15.8 ± 2.1
Intracellular NADH/NAD+ ratio 0.62 0.61 0.64
*The production of metabolites in the culture supernatant was determined by HPLC at 64 h during flask culture. Results were the average of three replicates with
error indicating standard error from the mean.
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production
In yeast, deleting the ilv5 gene (encoding AHAIR) can
block the subsequent step in the metabolism of α-
acetolactate, leading to the leakage of α-acetolactate
from the mitochondria and an increase in the availabil-
ity of cytosolic α-acetolactate [22]. Therefore, the gene
of ilv5 (CAGL0B03047g) was deleted to generate strain
MuA14. Compared to strain MuA13, the productions
of acetoin and 2,3-butaediol were slightly increased to
2.13 g/L and 1.45 g/L, higher by 8.6% and 13.2%, re-
spectively, but the cell growth decreased from 10.27 g/L to
9.96 g/L (Table 3). These results indicate that the deletion
of ilv5 had a slight effect on acetoin production at the ex-
pense of growth retardation . Furthermore, to decrease the
formation of ethanol, the ADH gene (CAGL0J01441g) was
disrupted on the basis of strain MuA13. As expected, etha-
nol production decreased to 2.72 g/L in strain MuA15,
which was 34.9% less than that produced by MuA13.
But interestingly, the levels of 2,3-butanediol and the
NADH/NAD+ ratio increased to 2.03 g/L and 0.64,
which were, respectively, 53.8% and 6.4% higher than
in MuA13, but the production of acetoin (2.08 g/L)
and the cell growth (10.13 g/L) were similar to those of
MuA13 (Table 3). Thus, blockage of the ethanol path-
way could enhance the carbon flux of the heterologous
pathway, but was more favorable for forming 2,3-buta-
nediol. Compared to strains MuA13 and MuA14,
MuA15 has more potential and is more effective in re-
distributing the carbon flux of pyruvate, and was then
selected to further improve acetoin production.Effect of nicotinic acid (NA) on acetoin production in a 5-L
fermenter
Based on the above results, it is suggested that the
higher level of NADH/NAD+ was responsible for the in-
creased 2,3-butanediol production in strain MuA15. To
further increase acetoin production, 10 mg/L of NA (the
precursor of NAD+) was added to regulate the level of
NADH/NAD+ based on a previous study [23]. As shown
in Figure 4F, the intracellular NADH/NAD+ ratio continu-
ously increased during the acetoin fermentation, but a
lower level of NADH/NAD+ was obtained due to the
addition of NA, so that the level of intracellular NADH/
NAD+ had decreased to 0.56 from 0.67 at the end of the
acetoin fermentation. As a result, a series of changes were
generated compared to the control (without addition of
NA) (Figure 4), as follows. (1) Owing to the addition of
NA, the strain showed a higher growth rate, in which the
cell concentration and glucose consumption rate were in-
creased by 16.9% and 17.6%, reaching 12.4 g/L DCW and
2.07 g/(L · h), respectively. (2) And correspondingly, the
production and productivity of acetoin were increased to
3.67 g/L and 0.05 g/(L · h) by 40.6% and 38.9%, respectively,
but the titer and productivity of 2,3-butanediol were signifi-
cantly decreased to 1.22 g/L and 0.02 g/(L · h), which were,
respectively, 118% and 115% lower than those of the con-
trol. Furthermore, the production of ethanol was also
slightly decreased by 15% to 3.09 g/L. Thus, the addition of
NA could effectively decrease the level of intracellular
NADH/NAD+, and then significantly inhibit the degrad-
ation of acetoin and the biosynthesis of 2,3-butanediol, in-
creasing the ratio of acetoin/2,3-butanediol markedly to
(A) (B) (C)
(D) (E) (F)







































































































Figure 4 Fermentation profiles for the control without the addition of NA (■) and with the addition of NA (▲) in a 5-L fermenter with
MuA15. The concentrations of glucose (A), DCW (B), acetoin (C), 2,3-butanediol (D), and ethanol (E), and the intracellular NADH/NAD+ ratio (F)
were measured and shown. The values were the mean derived from three independent biological experiments, and error bars indicated the
standard deviations.
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of C. glabrata to produce acetoin could be further en-
hanced through the regulation of intracellular NADH/
NAD+.
Discussion
As a pyruvate producer, the multi-auxotroph C. glabrata
can be further engineered for acetoin production. However,
compared with the larger accumulation of pyruvate, the
acetoin titers produced are very low due to the inhibited
pyruvate decarboxylation and intense spontaneous reaction
of NOD, leaving a substantial range for improving acetoin
production. Therefore, the GSMM i NX804 was employed
as a starting point and additional reactions were included
to account for the heterologous pathway. With the aid of in
silico simulation, the heterologous pathway was evaluated
as the more effective pathway for acetoin compared to the
original pathway in C. glabrata. Thus, a novel pathway was
designed and constructed in the cytosol, which was favor-
able for using pyruvate and transporting acetoin across the
cytomembrane, making the production of acetoin 43-fold
higher than that of the wild-type strain. This resultdemonstrated that GSMM i NX804 has predictive capabil-
ity for metabolic engineering. Recently, the number of
GSMMs available has sharply increased, and they are
widely used to explore the space of microbial biochemical
capabilities through promoting an understanding of metab-
olism on the global level [24-26]. For example, GSMM i
NX804 was applied to identify the bottleneck for producing
malate and provide a metabolic engineering strategy to sig-
nificantly improve malate production in C. glabrata [27].
Thus, systems metabolic engineering opens a novel path-
way for greatly improving the biochemical capabilities of
microorganisms. However, due to the lack of model
knowledge concerning microbial metabolism, regula-
tory mechanisms, and feedback inhibition, the applica-
tion of GSMM has also been restricted, and requires
further specific experimental investigation [17].
To construct a synthetic, composite pathway for acetoin
production in C. glabrata, a three-step approach was
employed in the present study. First, the candidate en-
zymes of ALS and ALDC were individually over-expressed
and tested for enzymatic activity and the production of me-
tabolites. Second, the best performing ALS and ALDC were
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cytosol, and evaluate their ability to produce acetoin. Fi-
nally, a push-and-pull strategy was adopted to achieve large
flux amplification through the optimization of promoters.
As a result, the concentrations of acetoin and 2,3-butane-
diol increased to 1.96 g/L and 1.32 g/L in the engineered
C. glabrata, respectively. However, the production of
ethanol also reached 3.68 g/L, which decreased the avail-
ability of pyruvate and offered another strategy for strain
improvement.
To further improve acetoin production, the ethanol
pathway was inhibited by disrupting the ADH gene.
Interestingly, the production of acetoin was unchanged,
but the level of 2,3-butanediol was increased by 53.8%
along with the increase in the NADH/NAD+ ratio. As
shown in Figure 1, the interconversion of acetoin and 2,3-
butanediol is an NADH-dependent reaction, and high levels
of NADH are favorable to form 2,3-butanediol. Thus regu-
lating the level of intracellular NAD+ could be an alterna-
tive approach for further improving acetoin production. In
previous studies, the water-forming NADH oxidase was
employed to regulate the intracellular NAD+ level, achiev-
ing a highly efficient acetoin production [28,29]. Here, the
precursor of NAD+, NA, was added to regulate the intracel-
lular NADH/NAD+ ratio during acetoin fermentation, in
which a lower level of intracellular NADH/NAD+ (0.56) was
obtained, significantly inhibiting the reduction of acetoin
and the biosynthesis of 2,3-butanediol. Consequently, the
production of acetoin was further increased to 3.67 g/L, sig-
nificantly increasing the ratio of acetoin/2,3-butanediol to
3.01 due to the insufficient reducing power [30,31]. How-
ever, the capacity to produce acetoin using C. glabrata was
still far less than that of prokaryotes, such as Serratia mar-
cescens H32 (75.2 g/L) [28], Bacillus licheniformis MEL09
(41.2 g/L) [32], and Klebsiella pneumonia (56.7 g/L) [3].
For example, B. amyloliquefaciens, a GRAS (generally
regarded as safe) microorganism, exhibits a high yield (0.43
g/g glucose), productivity (1.42 g/(L · h)), and production
(51.2 g/L) of acetoin during fed-batch fermentation [8].
Therefore, further enhancing the carbon flux of pyruvate
into acetoin and blocking the reduction of acetoin, for ex-
ample by disrupting butanediol dehydrogenase (BDH),
could be an effective approach to improving acetoin pro-
duction, and exploiting C. glabrata as a promising candi-
date for industrial acetoin production.
Conclusions
In this study, we report the first production of acetoin by C.
glabrata using the incorporation of systems metabolic en-
gineering with cofactor engineering, significantly increasing
the acetoin production to 3.67 g/L from trace amounts.
However, a high concentration of pyruvate (15 g/L) also ac-
cumulated in the engineered strain, leaving substantial
space for strain improvement. Actually, the carboligasereaction provides another pathway for acetoin production
in yeast, in which pyruvate decarboxylase (PDC) catalyzes
the irreversible non-oxidative decarboxylation of pyruvate
and acetaldehyde to produce acetoin [33,34]. But for C.
glabrata, pyruvate decarboxylation is strictly regulated by
thiamine, and had become the rate-limiting step for produ-
cing acetoin. Therefore, increasing the activity of pyruvate
decarboxylase and the availability of intracellular acetalde-
hyde may provide a novel opportunity to produce acetoin
in a future study.
Methods
Strains and plasmids
Escherichia coli JM109 was purchased from Invitrogen and
used for plasmid construction. The C. glabrata strains used
were generated from Candida glabrata CCTCC M202019.
More information about plasmids and strains is given in
Table 4.
Plasmid construction and transformation
Standard cloning and bacterial transformations were per-
formed according to Sambrook and Russell [35]. The fol-
lowing genes: ALS and ALDC from B. subtilis, B. pumilus,
B. amyloliquefaciens and E. coli, were codon-optimized
for expression in C. glabrata and synthesized by Sangon
Biotechnology (Shanghai, China). These genes were gel
extracted and inserted into the desired plasmid multi-
cloning sites. In all cases, PCR was performed using
TaKaRa Pyrobest DNA Polymerase (Takara Bio Inc,
Shiga, Japan). All plasmids and genes were sequenced
to ensure the correct identity of the insert prior to
transformations. Yeast strains were transformed using
the lithium acetate method [36].
Construction of deletion strains
Inactivation of ilv5 and ADH was achieved according to
the method previously described [36]. The ilv5::arg8 and
ADH::arg8 cassettes were constructed by fused PCR
(Additional file 2), and transformed into the C. glabrata
strain by electroporation. The transformants were identi-
fied as Arg+ prototrophic colonies on SM-U plates, and
confirmed by colony PCR.
Medium
During construction, strains were grown and maintained in
Yeast peptone dextrose medium (YPD), minimal medium
(MM), and supplement medium (SM) as follows. YPD: 10
g/L of yeast extract, 20 g/L of peptone, 20 g/L of glucose;
MM: 20 g/L of glucose, 1.0 g/L of KH2PO4, 0.5 g/L of
MgSO4, 10 g/L of (NH4)2SO4; and SM: MM with 80 mg/L
of uracil or 40 mg/L of arginine (SM-U, for Δ ura 3 mutant;
SM-A, for Δ arg 8 mutant); MM with 80 mg/L of uracil
and 40 mg/L of arginine (SM-UA; for Δ ura 3 Δ arg 8 mu-
tant); MM with 80 mg/L of branched-chain amino acids
Table 4 Strains and plasmids used
Strains/plasmids Relevant characteristics Reference
Plasmids
pY26 2 μm, AmpR, URA3, PGPD, PTEF Lab. collection
pYX212 2 μm, AmpR, URA3, PTPI Lab. collection
pY36 2 μm, AmpR, URA3, PTEF, PTEF This study
pY16 2 μm, AmpR, URA3, PTPI, PTPI This study
pY46 2 μm, AmpR, URA3, PGPD, PGPD This study
pYX212-BaALS Codon-optimized ALS from B. amyloliquefaciens This study
pYX212-BpALS Codon-optimized ALS from Bacillus pumilus This study
pYX212-BsALS Codon-optimized ALS from B. subtilis This study
pYX212-EcALS Codon-optimized ALS from E. coli This study
pYX212-BaALDC Codon-optimized ALDC from B. amyloliquefaciens This study
pYX212-BpALDC Codon-optimized ALDC from B. pumilus This study
pYX212-BsALDC Codon-optimized ALDC from B. subtilis This study
pYX212-EcALDC Codon-optimized ALDC from E. coli This study
pY16-TPI-BsALS-TPI-BaALDC Codon-optimized ALS and ALDC under TPI promoter This study
pY26-TEF-BsALS-GPD-BaALDC Codon-optimized ALS and ALDC under TEF and GPD promoter This study
pY26-GPD-BsALS-TEF-BaALDC Codon-optimized ALS and ALDC under GPD and TEF promoter This study
pY36-TEF-BsALS-TEF-BaALDC Codon-optimized ALS and ALDC under TEF promoter This study
pY46-GPD-BsALS-GPD-BaALDC Codon-optimized ALS and ALDC under GPD promoter This study
strains
C. glabrataCCTCC M202019 Multivitamin (thiamine, biotin, nicotinic acid and pyridoxine) auxotroph [37]
C. glabrataΔura3ΔArg8 The mutant derived from C. glabrata CCTCC M202019 [36]
MuA0 C. glabrata Δura3ΔArg8 (pYX212) This study
MuA1 C. glabrata Δura3ΔArg8 (pYX212-BaALS) This study
MuA2 C. glabrata Δura3ΔArg8 (pYX212-BpALS) This study
MuA3 C. glabrata Δura3ΔArg8 (pYX212-BsALS) This study
MuA4 C. glabrata Δura3ΔArg8 (pYX212-EcALS) This study
MuA5 C. glabrata Δura3ΔArg8 (pYX212-BaALDC) This study
MuA6 C. glabrata Δura3ΔArg8 (pYX212-BpALDC) This study
MuA7 C. glabrata Δura3ΔArg8 (pYX212-BsALDC) This study
MuA8 C. glabrata Δura3ΔArg8 (pYX212-EcALDC) This study
MuA9 C. glabrata Δura3ΔArg8 (pY16-TPI-BsALS-TPI-BaALDC) This study
MuA10 C. glabrata Δura3ΔArg8 (pY46-GPD-BsALS-GPD-BaALDC) This study
MuA11 C. glabrata Δura3ΔArg8 (pY36-TEF-BsALS-TEF-BaALDC) This study
MuA12 C. glabrata Δura3ΔArg8 (pY26-GPD-BsALS-TEF-BaALDC) This study
MuA13 C. glabrata Δura3ΔArg8 (pY26-TEF-BsALS-GPD-BaALDC) This study
MuA14 C. glabrata Δura3ΔArg8Δilv5 (pY26-TEF-BsALS-GPD-BaALDC) This study
MuA15 C. glabrata Δura3ΔArg8ΔADH (pY26-TEF-BsALS-GPD-BaALDC) This study
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pantothenate (SM-BP; for Δ ilv 5 mutant); and MM
with 80 mg/L of uracil, 40 mg/L of arginine, 80 mg/L of
branched-chain amino acids, and 30 mg/L of calcium
pantothenate (SM-UABP; for Δ ura 3 Δ arg 8 Δ ilv 5
mutant).During the fermentation, the medium for seed culture
(medium A) consisting of 20 g/L glucose, 7 g/L urea, 5
g/L KH2PO4, 0.8 g/L MgSO4 · 7H2O, 3 g/L sodium acet-
ate (15 g/L agar for solid medium); and the fermentation
medium (medium B) containing 100 g/L of glucose, 3
g/L of urea, 7 g/L of KH2PO4, 0.8 g/L of MgSO4 · 7H2O,
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mg/L of NA, 0.02 mg/L of thiamine, 0.04 mg/L of biotin,
and 0.4 mg/L of pyridoxine-HCl) was added to all media
(1% V/V). When necessary, the nutrients of uracil, arginine,
branched-chain amino acids, and calcium pantothenate
were added to overcome auxotrophy. Transformed E. coli
JM109 cells were grown at 37 C in Luria-Bertani (LB)
medium containing 100 μg/mL of ampicillin.
Culture conditions
The seed culture was cultivated in a flask (25/250 mL
medium A, 200 rpm, 30 C) for 24 h. Fermentation (50/500
mL medium B) was carried out in shake-flask culture (200
rpm, 30 C) using 40 g/L of CaCO3 as the buffering agent.
Batch-fermentation was carried out in a 5-L jar fermenter
(New Brunswick Scientific, Enfield, CT, USA) with 2.5 L of
medium B (using 120 g/L glucose) under the conditions:
the pH was controlled at 5.0 using 8 mol/L NaOH; the agi-
tation speed and aeration rate were controlled at 400 rpm
and 1.5 L/min; and performed at 30 C.
Analytical methods
Cell growth was determined by measuring the optical
density at 660 nm (OD660) using a UV–VIS spectropho-
tometer (Shimadzu UV mini 1240, Tokyo, Japan). The
dry cell weight (DCW) was calculated using the DCW/
OD660 ratio (DCW (g/L) = 0.23 OD660) according to a
predetermined calibration line [37].
For extracellular metabolites analysis, the concentra-
tions of glucose, ethanol, acetate, pyruvate, acetoin, and
2,3-butanediol were determined with a high performance
liquid chromatography (HPLC) system (Dionex UltiMate
3000 Series, Thermo Scientific, USA) equipped with a
Bio-Rad Aminex HPX-87H column (300 × 7.8 mm) and
a refractive index detector (RID) [8]. Extraction and de-
tection of intracellular NADH and NAD+ were carried
out as previously described [38]. A 40-mL sample was
collected and frozen in liquid nitrogen for 60 s, and then
freeze-dried for 24 h and thawed in a solution contain-
ing 50 mM KOH, 30% ethanol, and 22 mM borate. After
the pH was adjusted to 9.0-9.4 with 3 M HCl, extracted
samples were centrifuged at 10,000 × g for 10 min, and
then the supernatant was removed and its components
were detected using HPLC. To analyze intracellular me-
tabolites, samples were taken with a specialized rapid-
sampling setup [39], and the intracellular metabolites
were extracted with the method of freezing-thawing in
methanol [40].
Determination of α-acetolactate and diacetyl was ac-
complished as described in previous reports [41] with
minor modifications. Briefly, using 4 M H2SO4 to restrict
the spontaneous decarboxylation of α-acetolactate to diace-
tyl before the analysis, and then the samples were examined
using headspace gas chromatography with flame ionizationdetector (HS-GC-FID). During headspace at 70 C for 30
min in a low-pH environment, α-acetolactate was con-
verted to acetoin, while diacetyl remained unchanged.
Thus, α-acetolactate was quantified from the difference in
the concentration of acetoin between the GC and HPLC
results. HS-GC-FID analyses were performed using a gas
chromatograph (GC-2010; Shimadzu Co., Kyoto, Japan),
and analyte separation was accomplished on a capillary
column (PEG-20 M, 30 m 0.32 mm I.D.). Helium was
used as the carrier gas at a flow rate of 1.2 mL/min. The
injection and detector temperatures were 200 C and 250
C, respectively, and the temperature program was as fol-
lows: 5 min at 40 C, subsequent increase to 180 C at the
rate of 10 C per min, and 5 min at 180 C.
To measure ALDC and ALS activities, cells were har-
vested by centrifugation, and the extracts were prepared for
assaying enzyme activity. ALDC activity was measured by
the method of Loken and Stormer [42], and ALS activity
was measured by the Atsumi method [41]. Protein concen-
tration was determined by the Lowry method with bovine
serum albumin as the standard [43].In silico simulation
The impact of a heterologous pathway on cell growth
and acetoin production was simulated in silico by flux
balance analysis (FBA) using the GSMM of C. glabrata i
NX804, comprised of 804 genes, 1287 reactions, and 1025
metabolites (Additional file 1b) [15], in which the reactions
representing the heterologous enzymatic activities of ALS
and ALDC were added to the model. First, maximum cell
growth was set as the initial objective in the modified
model. Subsequently, the theoretical maximum value of
acetoin production was obtained using acetoin as the ob-
jective when the cell growth was decreased to 90% μmax.
FBA simulations were performed using COBRA Toolbox-
2.0 through the MATLAB interface, with GLPK as the lin-
ear programming solver [44].Additional files
Additional file 1a: Additional descriptions for Figure 2. A list of the
corresponding enzymes, reaction equations and subsystems for target
reaction listed in Table S1. b: Additional descriptions for Figure 2. A list of
additional description of the model i NX804 for in silico simulation.
Additional file 2: The construction of deletion cassettes for Figure S1.Abbreviations
ALS: Acetolactate synthase; ALDC: Acetolactate decarboxylase;
GSMM: Genome-scale metabolic model; NOD: Non-enzymatic oxidative
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NA: Nicotinic acid; BCAAs: Branched chain amino acids; 3-PG: 3-phosphate-
glyceraldehyde.
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